NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the broadening of the intellectual property portfolio of its wholly owned subsidiary, Intelligent Fingerprinting Limited, with the grant of a new European patent with unitary effect for its ground-breaking DSR-Plus Cartridge Reader. This latest achievement follows the successful protection of the same technology in the United Kingdom and marks another significant milestone in the Company’s expansion and protection of its intellectual property.
The European patent further confirms the uniqueness and innovation of the technology behind the DSR-Plus Cartridge Reader. The DSR-Plus Cartridge Reader, known for its proprietary technology in drug screening through fingerprint sweat analysis, provides a non-invasive and rapid method designed to accurately detect drug use. This technology is particularly valuable in workplaces and safety-critical industries, offering a discreet and hygienic testing solution.
With the European patent secured, the Company leveraged the new streamlined unitary patent scheme to bring the patent into effect in 17 European countries. This strategic move underscores the Company’s commitment to expanding its global footprint and offering advanced solutions to a broader market.
Harry Simeonidis, President and CEO at Intelligent Bio Solutions, commented, “The grant of the European patent is a testament to the ingenuity and hard work of our team. It fortifies our intellectual property portfolio and paves the way for our expansion into the European market. We are excited about the prospects of bringing our innovative technology to more organizations and contributing to safer and healthier workplaces across Europe.”
The DSR-Plus Cartridge Reader, designed for simplicity and efficiency, collects sweat samples from fingerprints in under a minute and delivers results in less than ten minutes. This innovative approach is revolutionizing drug screening practices, offering a dignified and effective alternative to conventional methods.
Visit INBS’ website for more information about Intelligent Fingerprinting and the DSR-Plus Cartridge Reader.
https://www.globenewswire.com/news-release/2024/04/11/2861490/0/en/Intelligent-Bio-Solutions-Subsidiary-Broadens-Intellectual-Property-Portfolio-with-Grant-of-New-European-Patent-with-Unitary-Effect-for-Innovative-Intelligent-Fingerprinting-DSR-Pl.html